Biogen Idec (BIIB) Names Douglas Williams as EVP of R&D, Steven Holtzman as EVP of Corp. Development
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) announced that they have appointed Douglas E. Williams ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
